APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sitagliptin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Sitagliptin Market Analysis and Forecast 2026-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchSitagliptin Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Sitagliptin Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Sitagliptin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sitagliptin Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Sitagliptin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sitagliptin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sitagliptin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Sitagliptin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Sitagliptin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Sitagliptin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Sitagliptin include Yonta, Baoling Pharma, Merck, De Xiang Pharmaceutical&Chemicals, Haikang Pharma and Phebra, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sitagliptin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Sitagliptin, also provides the sales of main regions and countries. Of the upcoming market potential for Sitagliptin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sitagliptin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sitagliptin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sitagliptin sales, projected growth trends, production technology, application and end-user industry.

Sitagliptin Segment by Company

Yonta

Baoling Pharma

Merck

De Xiang Pharmaceutical&Chemicals

Haikang Pharma

Phebra

Sitagliptin Segment by Type

Injection

Tablets

Sitagliptin Segment by Application

Diabetes

Epilepsy

Others

Sitagliptin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sitagliptin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sitagliptin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sitagliptin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Sitagliptin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Sitagliptin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sitagliptin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sitagliptin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Manufacturers Table 3. Tablets Major Manufacturers Table 4. Global Sitagliptin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Diabetes Major Manufacturers Table 6. Epilepsy Major Manufacturers Table 7. Others Major Manufacturers Table 8. Sitagliptin Industry Trends Table 9. Sitagliptin Industry Drivers Table 10. Sitagliptin Industry Opportunities and Challenges Table 11. Sitagliptin Industry Restraints Table 12. Global Sitagliptin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Sitagliptin Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Sitagliptin Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Sitagliptin Revenue Market Share by Region (2021-2026) Table 16. Global Sitagliptin Revenue Market Share by Region (2027-2032) Table 17. Global Sitagliptin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Sitagliptin Sales by Region (2021-2026) & (K Units) Table 19. Global Sitagliptin Sales by Region (2027-2032) & (K Units) Table 20. Global Sitagliptin Sales Market Share by Region (2021-2026) Table 21. Global Sitagliptin Sales Market Share by Region (2027-2032) Table 22. Global Sitagliptin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Sitagliptin Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Sitagliptin Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Sitagliptin Sales Market Share by Manufacturers (2021-2026) Table 26. Global Sitagliptin Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Sitagliptin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Sitagliptin Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Sitagliptin Manufacturers, Product Type & Application Table 30. Global Sitagliptin Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Sitagliptin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Sitagliptin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Sitagliptin Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Sitagliptin Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Sitagliptin Revenue Market Share by Type (2021-2026) Table 37. Global Sitagliptin Revenue Market Share by Type (2027-2032) Table 38. Global Sitagliptin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Sitagliptin Sales by Type (2021-2026) & (K Units) Table 40. Global Sitagliptin Sales by Type (2027-2032) & (K Units) Table 41. Global Sitagliptin Sales Market Share by Type (2021-2026) Table 42. Global Sitagliptin Sales Market Share by Type (2027-2032) Table 43. Global Sitagliptin Price by Type (2021-2026) & (US$/Unit) Table 44. Global Sitagliptin Price by Type (2027-2032) & (US$/Unit) Table 45. Global Sitagliptin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Sitagliptin Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Sitagliptin Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Sitagliptin Revenue Market Share by Application (2021-2026) Table 49. Global Sitagliptin Revenue Market Share by Application (2027-2032) Table 50. Global Sitagliptin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Sitagliptin Sales by Application (2021-2026) & (K Units) Table 52. Global Sitagliptin Sales by Application (2027-2032) & (K Units) Table 53. Global Sitagliptin Sales Market Share by Application (2021-2026) Table 54. Global Sitagliptin Sales Market Share by Application (2027-2032) Table 55. Global Sitagliptin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Sitagliptin Price by Application (2027-2032) & (US$/Unit) Table 57. Yonta Company Information Table 58. Yonta Business Overview Table 59. Yonta Sitagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Yonta Sitagliptin Product Portfolio Table 61. Yonta Recent Development Table 62. Baoling Pharma Company Information Table 63. Baoling Pharma Business Overview Table 64. Baoling Pharma Sitagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Baoling Pharma Sitagliptin Product Portfolio Table 66. Baoling Pharma Recent Development Table 67. Merck Company Information Table 68. Merck Business Overview Table 69. Merck Sitagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Merck Sitagliptin Product Portfolio Table 71. Merck Recent Development Table 72. De Xiang Pharmaceutical&Chemicals Company Information Table 73. De Xiang Pharmaceutical&Chemicals Business Overview Table 74. De Xiang Pharmaceutical&Chemicals Sitagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. De Xiang Pharmaceutical&Chemicals Sitagliptin Product Portfolio Table 76. De Xiang Pharmaceutical&Chemicals Recent Development Table 77. Haikang Pharma Company Information Table 78. Haikang Pharma Business Overview Table 79. Haikang Pharma Sitagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Haikang Pharma Sitagliptin Product Portfolio Table 81. Haikang Pharma Recent Development Table 82. Phebra Company Information Table 83. Phebra Business Overview Table 84. Phebra Sitagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Phebra Sitagliptin Product Portfolio Table 86. Phebra Recent Development Table 87. North America Sitagliptin Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Sitagliptin Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Sitagliptin Sales by Type (2021-2026) & (K Units) Table 90. North America Sitagliptin Sales by Type (2027-2032) & (K Units) Table 91. North America Sitagliptin Sales Price by Type (2021-2026) & (US$/Unit) Table 92. North America Sitagliptin Sales Price by Type (2027-2032) & (US$/Unit) Table 93. North America Sitagliptin Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Sitagliptin Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Sitagliptin Sales by Application (2021-2026) & (K Units) Table 96. North America Sitagliptin Sales by Application (2027-2032) & (K Units) Table 97. North America Sitagliptin Sales Price by Application (2021-2026) & (US$/Unit) Table 98. North America Sitagliptin Sales Price by Application (2027-2032) & (US$/Unit) Table 99. North America Sitagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Sitagliptin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Sitagliptin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Sitagliptin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 103. North America Sitagliptin Sales by Country (2021-2026) & (K Units) Table 104. North America Sitagliptin Sales by Country (2027-2032) & (K Units) Table 105. North America Sitagliptin Sales Price by Country (2021-2026) & (US$/Unit) Table 106. North America Sitagliptin Sales Price by Country (2027-2032) & (US$/Unit) Table 107. United States Sitagliptin Revenue (2021-2032) & (US$ Million) Table 108. Canada Sitagliptin Revenue (2021-2032) & (US$ Million) Table 109. Europe Sitagliptin Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Sitagliptin Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Sitagliptin Sales by Type (2021-2026) & (K Units) Table 112. Europe Sitagliptin Sales by Type (2027-2032) & (K Units) Table 113. Europe Sitagliptin Sales Price by Type (2021-2026) & (US$/Unit) Table 114. Europe Sitagliptin Sales Price by Type (2027-2032) & (US$/Unit) Table 115. Europe Sitagliptin Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Sitagliptin Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Sitagliptin Sales by Application (2021-2026) & (K Units) Table 118. Europe Sitagliptin Sales by Application (2027-2032) & (K Units) Table 119. Europe Sitagliptin Sales Price by Application (2021-2026) & (US$/Unit) Table 120. Europe Sitagliptin Sales Price by Application (2027-2032) & (US$/Unit) Table 121. Europe Sitagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Sitagliptin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Sitagliptin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Sitagliptin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. Europe Sitagliptin Sales by Country (2021-2026) & (K Units) Table 126. Europe Sitagliptin Sales by Country (2027-2032) & (K Units) Table 127. Europe Sitagliptin Sales Price by Country (2021-2026) & (US$/Unit) Table 128. Europe Sitagliptin Sales Price by Country (2027-2032) & (US$/Unit) Table 129. Germany Sitagliptin Revenue (2021-2032) & (US$ Million) Table 130. France Sitagliptin Revenue (2021-2032) & (US$ Million) Table 131. U.K. Sitagliptin Revenue (2021-2032) & (US$ Million) Table 132. Italy Sitagliptin Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Sitagliptin Revenue (2021-2032) & (US$ Million) Table 134. China Sitagliptin Revenue by Type (2021-2026) & (US$ Million) Table 135. China Sitagliptin Revenue by Type (2027-2032) & (US$ Million) Table 136. China Sitagliptin Sales by Type (2021-2026) & (K Units) Table 137. China Sitagliptin Sales by Type (2027-2032) & (K Units) Table 138. China Sitagliptin Sales Price by Type (2021-2026) & (US$/Unit) Table 139. China Sitagliptin Sales Price by Type (2027-2032) & (US$/Unit) Table 140. China Sitagliptin Revenue by Application (2021-2026) & (US$ Million) Table 141. China Sitagliptin Revenue by Application (2027-2032) & (US$ Million) Table 142. China Sitagliptin Sales by Application (2021-2026) & (K Units) Table 143. China Sitagliptin Sales by Application (2027-2032) & (K Units) Table 144. China Sitagliptin Sales Price by Application (2021-2026) & (US$/Unit) Table 145. China Sitagliptin Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Sitagliptin Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Sitagliptin Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Sitagliptin Sales by Type (2021-2026) & (K Units) Table 149. Asia Sitagliptin Sales by Type (2027-2032) & (K Units) Table 150. Asia Sitagliptin Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Asia Sitagliptin Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Asia Sitagliptin Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Sitagliptin Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Sitagliptin Sales by Application (2021-2026) & (K Units) Table 155. Asia Sitagliptin Sales by Application (2027-2032) & (K Units) Table 156. Asia Sitagliptin Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Asia Sitagliptin Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Sitagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Sitagliptin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Sitagliptin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Sitagliptin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Asia Sitagliptin Sales by Country (2021-2026) & (K Units) Table 163. Asia Sitagliptin Sales by Country (2027-2032) & (K Units) Table 164. Asia Sitagliptin Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Asia Sitagliptin Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Japan Sitagliptin Revenue (2021-2032) & (US$ Million) Table 167. South Korea Sitagliptin Revenue (2021-2032) & (US$ Million) Table 168. India Sitagliptin Revenue (2021-2032) & (US$ Million) Table 169. Australia Sitagliptin Revenue (2021-2032) & (US$ Million) Table 170. China Taiwan Sitagliptin Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Sitagliptin Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Sitagliptin Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Sitagliptin Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Sitagliptin Sales by Type (2021-2026) & (K Units) Table 175. SAMEA Sitagliptin Sales by Type (2027-2032) & (K Units) Table 176. SAMEA Sitagliptin Sales Price by Type (2021-2026) & (US$/Unit) Table 177. SAMEA Sitagliptin Sales Price by Type (2027-2032) & (US$/Unit) Table 178. SAMEA Sitagliptin Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Sitagliptin Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Sitagliptin Sales by Application (2021-2026) & (K Units) Table 181. SAMEA Sitagliptin Sales by Application (2027-2032) & (K Units) Table 182. SAMEA Sitagliptin Sales Price by Application (2021-2026) & (US$/Unit) Table 183. SAMEA Sitagliptin Sales Price by Application (2027-2032) & (US$/Unit) Table 184. SAMEA Sitagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Sitagliptin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Sitagliptin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Sitagliptin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. SAMEA Sitagliptin Sales by Country (2021-2026) & (K Units) Table 189. SAMEA Sitagliptin Sales by Country (2027-2032) & (K Units) Table 190. SAMEA Sitagliptin Sales Price by Country (2021-2026) & (US$/Unit) Table 191. SAMEA Sitagliptin Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Brazil Sitagliptin Revenue (2021-2032) & (US$ Million) Table 193. Argentina Sitagliptin Revenue (2021-2032) & (US$ Million) Table 194. Chile Sitagliptin Revenue (2021-2032) & (US$ Million) Table 195. Colombia Sitagliptin Revenue (2021-2032) & (US$ Million) Table 196. Peru Sitagliptin Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Sitagliptin Revenue (2021-2032) & (US$ Million) Table 198. Israel Sitagliptin Revenue (2021-2032) & (US$ Million) Table 199. UAE Sitagliptin Revenue (2021-2032) & (US$ Million) Table 200. Turkey Sitagliptin Revenue (2021-2032) & (US$ Million) Table 201. Iran Sitagliptin Revenue (2021-2032) & (US$ Million) Table 202. Egypt Sitagliptin Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Sitagliptin Distributors List Table 206. Sitagliptin Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Sitagliptin Image Figure 2. Global Sitagliptin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sitagliptin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Tablets Image Figure 6. Global Sitagliptin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Sitagliptin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Diabetes Image Figure 9. Epilepsy Image Figure 10. Others Image Figure 11. Global Sitagliptin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Sitagliptin Revenue (2021-2032) & (US$ Million) Figure 13. Global Sitagliptin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Sitagliptin Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Sitagliptin Revenue Market Share by Region (2021-2032) Figure 16. Global Sitagliptin Sales (2021-2032) & (K Units) Figure 17. Global Sitagliptin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Sitagliptin Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Sitagliptin Sales YoY (2021-2032) & (K Units) Figure 20. Europe Sitagliptin Sales YoY (2021-2032) & (K Units) Figure 21. China Sitagliptin Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Sitagliptin Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Sitagliptin Sales YoY (2021-2032) & (K Units) Figure 24. Global Sitagliptin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Sitagliptin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Sitagliptin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Sitagliptin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Sitagliptin Revenue Market Share by Type (2021-2032) Figure 30. Global Sitagliptin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Sitagliptin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Sitagliptin Sales Market Share by Type (2021-2032) Figure 33. Global Sitagliptin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Sitagliptin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Sitagliptin Revenue Market Share by Application (2021-2032) Figure 36. Global Sitagliptin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Sitagliptin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Sitagliptin Sales Market Share by Application (2021-2032) Figure 39. North America Sitagliptin Revenue Share by Type (2021-2032) Figure 40. North America Sitagliptin Sales Share by Type (2021-2032) Figure 41. North America Sitagliptin Revenue Share by Application (2021-2032) Figure 42. North America Sitagliptin Sales Share by Application (2021-2032) Figure 43. North America Sitagliptin Revenue Share by Country (2021-2032) Figure 44. North America Sitagliptin Sales Share by Country (2021-2032) Figure 45. Europe Sitagliptin Revenue Share by Type (2021-2032) Figure 46. Europe Sitagliptin Sales Share by Type (2021-2032) Figure 47. Europe Sitagliptin Revenue Share by Application (2021-2032) Figure 48. Europe Sitagliptin Sales Share by Application (2021-2032) Figure 49. Europe Sitagliptin Revenue Share by Country (2021-2032) Figure 50. Europe Sitagliptin Sales Share by Country (2021-2032) Figure 51. China Sitagliptin Revenue Share by Type (2021-2032) Figure 52. China Sitagliptin Sales Share by Type (2021-2032) Figure 53. China Sitagliptin Revenue Share by Application (2021-2032) Figure 54. China Sitagliptin Sales Share by Application (2021-2032) Figure 55. Asia Sitagliptin Revenue Share by Type (2021-2032) Figure 56. Asia Sitagliptin Sales Share by Type (2021-2032) Figure 57. Asia Sitagliptin Revenue Share by Application (2021-2032) Figure 58. Asia Sitagliptin Sales Share by Application (2021-2032) Figure 59. Asia Sitagliptin Revenue Share by Country (2021-2032) Figure 60. Asia Sitagliptin Sales Share by Country (2021-2032) Figure 61. SAMEA Sitagliptin Revenue Share by Type (2021-2032) Figure 62. SAMEA Sitagliptin Sales Share by Type (2021-2032) Figure 63. SAMEA Sitagliptin Revenue Share by Application (2021-2032) Figure 64. SAMEA Sitagliptin Sales Share by Application (2021-2032) Figure 65. SAMEA Sitagliptin Revenue Share by Country (2021-2032) Figure 66. SAMEA Sitagliptin Sales Share by Country (2021-2032) Figure 67. Sitagliptin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Sitagliptin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablets
Applications
  • Diabetes
  • Epilepsy
  • Others
Companies covered
  • Yonta
  • Baoling Pharma
  • Merck
  • De Xiang Pharmaceutical&Chemicals
  • Haikang Pharma
  • Phebra

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Sitagliptin Market by Type
  3. 1.2.1 Global Sitagliptin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Tablets
  6. 1.3 Sitagliptin Market by Application
  7. 1.3.1 Global Sitagliptin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Diabetes
  9. 1.3.3 Epilepsy
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Sitagliptin Market Dynamics
  1. 2.1 Sitagliptin Industry Trends
  2. 2.2 Sitagliptin Industry Drivers
  3. 2.3 Sitagliptin Industry Opportunities and Challenges
  4. 2.4 Sitagliptin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Sitagliptin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Sitagliptin Revenue by Region
  3. 3.2.1 Global Sitagliptin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Sitagliptin Revenue by Region (2021-2026)
  5. 3.2.3 Global Sitagliptin Revenue by Region (2027-2032)
  6. 3.2.4 Global Sitagliptin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Sitagliptin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Sitagliptin Sales by Region
  9. 3.4.1 Global Sitagliptin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Sitagliptin Sales by Region (2021-2026)
  11. 3.4.3 Global Sitagliptin Sales by Region (2027-2032)
  12. 3.4.4 Global Sitagliptin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Sitagliptin Revenue by Manufacturers
  2. 4.1.1 Global Sitagliptin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Sitagliptin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Sitagliptin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Sitagliptin Sales by Manufacturers
  6. 4.2.1 Global Sitagliptin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Sitagliptin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Sitagliptin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Sitagliptin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Sitagliptin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Sitagliptin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Sitagliptin Manufacturers, Product Type & Application
  13. 4.7 Global Sitagliptin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Sitagliptin Market CR5 and HHI
  16. 4.8.2 2025 Sitagliptin Tier 1, Tier 2, and Tier 3
5 Sitagliptin Market by Type
  1. 5.1 Global Sitagliptin Revenue by Type
  2. 5.1.1 Global Sitagliptin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Sitagliptin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Sitagliptin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Sitagliptin Sales by Type
  6. 5.2.1 Global Sitagliptin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sitagliptin Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Sitagliptin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Sitagliptin Price by Type
6 Sitagliptin Market by Application
  1. 6.1 Global Sitagliptin Revenue by Application
  2. 6.1.1 Global Sitagliptin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Sitagliptin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Sitagliptin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Sitagliptin Sales by Application
  6. 6.2.1 Global Sitagliptin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Sitagliptin Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Sitagliptin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Sitagliptin Price by Application
7 Company Profiles
  1. 7.1 Yonta
  2. 7.1.1 Yonta Company Information
  3. 7.1.2 Yonta Business Overview
  4. 7.1.3 Yonta Sitagliptin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Yonta Sitagliptin Product Portfolio
  6. 7.1.5 Yonta Recent Developments
  7. 7.2 Baoling Pharma
  8. 7.2.1 Baoling Pharma Company Information
  9. 7.2.2 Baoling Pharma Business Overview
  10. 7.2.3 Baoling Pharma Sitagliptin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Baoling Pharma Sitagliptin Product Portfolio
  12. 7.2.5 Baoling Pharma Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Sitagliptin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Sitagliptin Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 De Xiang Pharmaceutical&Chemicals
  20. 7.4.1 De Xiang Pharmaceutical&Chemicals Company Information
  21. 7.4.2 De Xiang Pharmaceutical&Chemicals Business Overview
  22. 7.4.3 De Xiang Pharmaceutical&Chemicals Sitagliptin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 De Xiang Pharmaceutical&Chemicals Sitagliptin Product Portfolio
  24. 7.4.5 De Xiang Pharmaceutical&Chemicals Recent Developments
  25. 7.5 Haikang Pharma
  26. 7.5.1 Haikang Pharma Company Information
  27. 7.5.2 Haikang Pharma Business Overview
  28. 7.5.3 Haikang Pharma Sitagliptin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Haikang Pharma Sitagliptin Product Portfolio
  30. 7.5.5 Haikang Pharma Recent Developments
  31. 7.6 Phebra
  32. 7.6.1 Phebra Company Information
  33. 7.6.2 Phebra Business Overview
  34. 7.6.3 Phebra Sitagliptin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Phebra Sitagliptin Product Portfolio
  36. 7.6.5 Phebra Recent Developments
8 North America
  1. 8.1 North America Sitagliptin Market Size by Type
  2. 8.1.1 North America Sitagliptin Revenue by Type (2021-2032)
  3. 8.1.2 North America Sitagliptin Sales by Type (2021-2032)
  4. 8.1.3 North America Sitagliptin Price by Type (2021-2032)
  5. 8.2 North America Sitagliptin Market Size by Application
  6. 8.2.1 North America Sitagliptin Revenue by Application (2021-2032)
  7. 8.2.2 North America Sitagliptin Sales by Application (2021-2032)
  8. 8.2.3 North America Sitagliptin Price by Application (2021-2032)
  9. 8.3 North America Sitagliptin Market Size by Country
  10. 8.3.1 North America Sitagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Sitagliptin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Sitagliptin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Sitagliptin Market Size by Type
  2. 9.1.1 Europe Sitagliptin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Sitagliptin Sales by Type (2021-2032)
  4. 9.1.3 Europe Sitagliptin Price by Type (2021-2032)
  5. 9.2 Europe Sitagliptin Market Size by Application
  6. 9.2.1 Europe Sitagliptin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Sitagliptin Sales by Application (2021-2032)
  8. 9.2.3 Europe Sitagliptin Price by Application (2021-2032)
  9. 9.3 Europe Sitagliptin Market Size by Country
  10. 9.3.1 Europe Sitagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Sitagliptin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Sitagliptin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Sitagliptin Market Size by Type
  2. 10.1.1 China Sitagliptin Revenue by Type (2021-2032)
  3. 10.1.2 China Sitagliptin Sales by Type (2021-2032)
  4. 10.1.3 China Sitagliptin Price by Type (2021-2032)
  5. 10.2 China Sitagliptin Market Size by Application
  6. 10.2.1 China Sitagliptin Revenue by Application (2021-2032)
  7. 10.2.2 China Sitagliptin Sales by Application (2021-2032)
  8. 10.2.3 China Sitagliptin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Sitagliptin Market Size by Type
  2. 11.1.1 Asia Sitagliptin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Sitagliptin Sales by Type (2021-2032)
  4. 11.1.3 Asia Sitagliptin Price by Type (2021-2032)
  5. 11.2 Asia Sitagliptin Market Size by Application
  6. 11.2.1 Asia Sitagliptin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Sitagliptin Sales by Application (2021-2032)
  8. 11.2.3 Asia Sitagliptin Price by Application (2021-2032)
  9. 11.3 Asia Sitagliptin Market Size by Country
  10. 11.3.1 Asia Sitagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Sitagliptin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Sitagliptin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Sitagliptin Market Size by Type
  2. 12.1.1 SAMEA Sitagliptin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Sitagliptin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Sitagliptin Price by Type (2021-2032)
  5. 12.2 SAMEA Sitagliptin Market Size by Application
  6. 12.2.1 SAMEA Sitagliptin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Sitagliptin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Sitagliptin Price by Application (2021-2032)
  9. 12.3 SAMEA Sitagliptin Market Size by Country
  10. 12.3.1 SAMEA Sitagliptin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Sitagliptin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Sitagliptin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Sitagliptin Value Chain Analysis
  2. 13.1.1 Sitagliptin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Sitagliptin Production Mode & Process
  6. 13.2 Sitagliptin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Sitagliptin Distributors
  9. 13.2.3 Sitagliptin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst